The expression levels of the NR4A1 gene are significantly reduced in various cancer tissues such as bladder urothelial carcinoma, invasive breast cancer, and head and neck squamous cell carcinoma (Deng et al., 2022). This evidence concerns the gene NR4A1 and invasive breast carcinoma.